ENSC: Ensysce Biosciences Inc. Earnings per share for the last twelve months

Official company branding of Ensysce Biosciences (ENSC)

Patents for the MPAR platform provide Ensysce Biosciences (ENSC) with significant market power and margin potential. However, regulatory pressure and the expansion of new non-opioid analgesics are intensifying competition. The current trailing twelve-month net income per share clearly confirms these challenges, with the metric standing at -2.73. The absence of a stable cash flow leaves the company's financial position dependent on previously raised investments.

ENSC (Ensysce Biosciences) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/11/2026

Metric breakdowns and analytics for Ensysce Biosciences Inc. (ENSC)

- current quotes and average value forecast:
Price Chart Ensysce|ENSC - Fair Value Consensus
- market capitalization information:
Market Value Ensysce Biosciences, Inc.|ENSC - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Ensysce Biosciences|ENSC - Total Stockholders' Equity|Market Value to Book Value Ratio ensysce.com|ENSC - Total Business Assets
- debt and liquidity data:
Debt to Equity Ensysce Biosciences|ENSC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Ensysce|ENSC - Company Cumulative Debt|Debt to Book Capitalization Ratio Ensysce Biosciences, Inc.|ENSC - Long-Term Debt Volume|Company Short-Term Debts Ensysce Biosciences|Quick Ratio ensysce.com
- net income and valuation multiples indicators:
ENSC - Company Net Income|Future Profit Ensysce Biosciences|ENSC - Company Value to Net Income|Forward P/E Multiple Ensysce|ENSC - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Ensysce Biosciences, Inc.|ENSC - Operating income before deduction of amortization|Earnings per share for the last twelve months Ensysce Biosciences|ENSC - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months ensysce.com|ENSC - Expected net earnings per share growth this year|Earnings growth forecast for next year Ensysce Biosciences
Basic company analysis:ENSC - ensysce.com
Mass-produced product of Ensysce Biosciences

The diversification of the Ensysce Biosciences (ENSC) pipeline for opioid overdose protection directly impacts the business's financial stability. This indicator calculates the net income allocated per share over a rolling year, excluding the impact of security issuance. The metric allows for an assessment of the real return on capital without accounting for shareholder dilution. Analyzing the dynamics helps identify revenue stagnation in a timely manner. The current rolling year net income per share visualizes these trends.

Competitors of Ensysce Biosciences

INDV - Earnings per share for the last twelve months|Earnings per share for the trailing year COLL (collegiumpharma.com)|Cronos Group (CRON) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Canopy Growth Corp|HITI (High Tide Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aurora ACB|Earnings per share for the last twelve months Achieve Life Sciences (ACHV)|Skye Bioscience Inc. - Earnings per share for the last 12 months|Earnings per share for the last twelve months Anebulo Pharmaceuticals, Inc. ANEB|Net earnings per share for the last four quarters InterCure Ltd (INCR)|NTRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Nasus Pharma Ltd|igcinc.us (IGC) - Earnings per share for the last twelve months|MIRA - Net earnings per share for the last four quarters|FLGC (Flora Growth) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months IMC (IMCC)|Net earnings per share (EPS TTM) ADIL|ARTL - Net earnings per one share for the last twelve months|Titan Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year GNLN|InMed Pharmaceuticals Inc. - Net earnings per share (EPS TTM)|AKAN: Earnings per share for the last twelve months|ENVB: Net earnings per share (EPS TTM)|BGXX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Hempacco Co., Inc.